Despite the growing evidence of the importance of Q fever in resource limited settings, there is currently little active control of Q fever in sub-Saharan Africa, which is exemplified by a recent systematic review of C. burnetii epidemiology in Africa which failed to identify a single disease control study in the scientific literature.
This report provides recommendations issued by the US Centers for Disease Control and Prevention (CDC) for Q fever recognition, clinical and laboratory diagnosis, treatment, management, and reporting for health-care personnel and public health professionals. The guidelines address treatment of acute and chronic phases of Q fever illness in children, adults, and pregnant women, as well as management of occupational exposures.
At least 90 British military personnel have been diagnosed with confirmed cases of Q fever after serving in Helmand, Afghanistan, a British court heard this week.
Reports suggest a recent spate of cases of Q fever in rural areas likely comes from closer human exposure to livestock during times of drought.
Department of Primary Industries scientists are set to begin development of a new human Q Fever vaccine in collaboration with the Australian Rickettsial Reference Laboratory (ARRL).
The symptoms and signs of acute Q fever are extremely variable and the most valuable clue is exposure to infected meat.
This factsheet provides an overview of Q Fever including its etiology, transmission, diagnosis, disinfection, and treatment.
Q-fever is a zoonotic disease found worldwide, and is caused by a bacterium known as Coxiella burnetti.
The 43 Q fever patients are inhabitants of the region of Los Lagos and Los Ríos, with the majority working in the dairy industry.
The inhaled ciprofloxacin formulations are product candidates for the prevention and treatment of high threat and bioterrorism infections.